Cargando…
First trimester screening for trisomy 21 in gestational week 8-10 by ADAM12-S as a maternal serum marker
BACKGROUND: A disintegrin and metalloprotease 12 (ADAM12-S) has previously been reported to be significantly reduced in maternal serum from women with fetal aneuploidy early in the first trimester and to significantly improve the quality of risk assessment for fetal trisomy 21 in prenatal screening....
Autores principales: | Tørring, Niels, Ball, Susan, Wright, Dave, Sarkissian, Gaïané, Guitton, Marie, Darbouret, Bruno |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2984461/ https://www.ncbi.nlm.nih.gov/pubmed/21034452 http://dx.doi.org/10.1186/1477-7827-8-129 |
Ejemplares similares
-
Non-Invasive Epigenetic Detection of Fetal Trisomy 21 in First Trimester Maternal Plasma
por: Lim, Ji Hyae, et al.
Publicado: (2011) -
Detection of Embryonic Trisomy 21 in the First Trimester Using Maternal Plasma Cell-Free RNA
por: Weiner, Carl P., et al.
Publicado: (2022) -
Study on amniotic fluid metabolism in the second trimester of Trisomy 21
por: Liu, Xiaoting, et al.
Publicado: (2019) -
Application of an individualized nomogram in first‐trimester screening for trisomy 21
por: Sun, Y., et al.
Publicado: (2021) -
Diagnostic value of maternal alpha-fetoprotein variants in second-trimester biochemical screening for trisomy 21 and 18
por: Chen, Yiming, et al.
Publicado: (2022)